mallinckrodt endo merger

Mallinckrodt and Endo plan merger

Mallinckrodt and Endo plan merger as they look to recover from opioid litigation

The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in 2025 and at least $150 million of annual operating synergies by year three.

Reuters on MSN · 3d

Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger

Mallinckrodt and Endo , drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced plans Thursday to join forces in a deal valued at $6.7 billion.

MyChesCo on MSN · 16h

Mallinckrodt and Endo Announce Merger to Build Diversified Pharmaceuticals Powerhouse

Pharmaceutical leaders Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have entered an agreement to merge, creating a global, diversified company poised to deliver enhanced patient

MedCity News3d

Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal

Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with ...

3don MSN

Mallinckrodt and Endo to combine in stock and cash transaction

Endo (NDOI) stock gains as the company is in pact with Mallinckrodt (MNKTQ) to merge in a $6.7B deal, creating a Dublin-based ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Mallinckrodt and Endo plan merger

Trending now